All In MedTech

Device Trial Radar · NCT07047924

A Clinical Trial Assessing the Safety and Effectiveness of Orthokeratology Lenses in Patients With Myopia and Myopic Astigmatism

A Prospective, Multi-centre, Single-Arm Clinical Trial of Orthokeratology Lenses (MCOK-01) in Subjects With Myopia and Myopic Astigmatism

Last checked: Nov 19, 2026Latest source record: Jul 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

220

Planned (sponsor's estimate)

Start

Jul 1, 2025

Primary completion

Dec 1, 2026

Study completion Dec 1, 2026

Sponsor

Lead sponsor
Menicon Co., Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Jul 2, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 6 years, up to 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, multi-centre, single-arm clinical trial to evaluate the effectiveness and safety of MCOK-01 lenses in patients with myopia and myopic astigmatism who need dioptric correction. A maximum number of 220 participants are planned to be enrolled , with a minimum of 150 planned to complete the trial (30% dropout). All participants will be enrolled in Australia. Enrolled participants will wear the lenses every night for up to 12 months, removing them upon waking. 8 follow up visits will be completed during treatment, after: 1 day, 1 week, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months of wearing the lenses.

Conditions

  • Myopia
  • Myopic Astigmatism

Interventions

  • MCOK-01Device

    The investigational device is a Rigid Gas Permeable contact lenses for orthokeratology. MCOK-01 applied the reverse geometry design and adopted the lens material which possesses the highest oxygen permeability among all the materials for orthokeratology lens.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Lines of improvement of monocular uncorrected distance visual acuityTime frame: 12-months following enrolment
  2. Proportion of eyes achieved uncorrected distance visual acuity of ≤0.30 logMAR, ≤0.20 logMAR, ≤0.10 logMAR, and ≤0.00 logMARTime frame: 1 month, 3 months, 6 months, 9 months, and 12 months following enrolment
  3. A level of attempted versus achieved reduction in manifest refractive errorTime frame: 12 months following enrolment

4 more outcomes with a free account

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Eyecare Kids

    Hillsdale, New South Wales, Australia

  • UNSW School of Optometry and Vision Science

    Sydney, New South Wales, Australia

  • Queensland University of Technology Optometry and Vision Science

    Kelvin Grove, Queensland, Australia

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.